Built for US nurse practitioners — and the practices around them.
Nurvivo is built by Progranza Inc., a healthcare technology company founded by Shyam Sembagoundar.
With 18+ years in IT including enterprise healthcare systems for government agencies, Progranza builds AI-powered clinical tools that let healthcare practitioners focus on what matters — their patients.
Nurvivo NP Care is in Founding Beta for independent US nurse practitioners — NP-specific note templates, scope-of-practice aware, ICD-10 and CPT/E&M coding, and HIPAA-native. The first 20 NPs get free access while we build it together.
A HIPAA version of Nurvivo Dental with CDT codes for US practices is on the 2027 roadmap. The Nurvivo platform will also expand to serve Optometrists and Chiropractors — all built on the same principle: intelligent tools that respect your workflow and your patients' privacy.
Built with clinicians
Designed for nurse practitioners in every state.
Our mission
Give clinicians their time back.
Nurvivo exists to give healthcare practitioners their time back. We believe clinicians became practitioners to care for patients, not to chart. Every product in the Nurvivo suite is built to reclaim hours from documentation and put them back into care, family, and rest.
Leadership
Founder
Shyam Sembagoundar
Founder & CEO, Progranza Inc.
18+ years in IT including enterprise healthcare systems for government agencies. Shyam founded Progranza Inc. to build AI clinical tools that respect clinician workflow and patient privacy from day one.
Team
Built by clinicians and engineers.
Coming soon
We're hiring clinicians and senior engineers across Canada and the US.
Want to join? hello@nurvivo.com
Company
Founded
2024
Headquarters
Ontario, Canada
Parent company
Progranza Inc.
Products
Dental (live) · NP Care (Founding Beta)
PHIPA & PIPEDA aligned
Built from day one to meet Canadian health-privacy law.
HIPAA-native (US)
BAA included with every Nurvivo NP Care subscription.
Zero training policy
Your clinical data is never used to train external models.